MedTrace Logo

Reconstruction of Jaw Bone Using Mesenchymal Stem Cells

NCT02751125 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2020-03-03

No results posted yet for this study

Summary

This pilot study is aimed to reconstruct atrophied posterior alveolar mandibular ridges using biomaterial and autologous bone marrow derived stem cells (BMMSC) and to insert an implant into the new bone in a prosthetically guided position.

Conditions

  • Bone Atrophy

Interventions

DRUG

BCP with autologous mesenchymal stem cells (MSC).

Augmentation of narrow alveolar ridge with BCP and MSC

Sponsors & Collaborators

  • University of Ulm

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • Université de Nantes

    collaborator OTHER

  • University of Bergen

    lead OTHER

Principal Investigators

  • Cecilie Gjerde, DDS · University of Bergen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-03-01
Completion
2020-03-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02751125 on ClinicalTrials.gov